These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35669767)

  • 21. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19.
    Dang TTT; Anzurez A; Nakayama-Hosoya K; Miki S; Yamashita K; de Souza M; Matano T; Kawana-Tachikawa A
    Microbiol Spectr; 2023 Aug; 11(4):e0214323. PubMed ID: 37428088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.
    Gallais F; Gantner P; Bruel T; Velay A; Planas D; Wendling MJ; Bayer S; Solis M; Laugel E; Reix N; Schneider A; Glady L; Panaget B; Collongues N; Partisani M; Lessinger JM; Fontanet A; Rey D; Hansmann Y; Kling-Pillitteri L; Schwartz O; De Sèze J; Meyer N; Gonzalez M; Schmidt-Mutter C; Fafi-Kremer S
    EBioMedicine; 2021 Sep; 71():103561. PubMed ID: 34455390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes associated with SARS-CoV-2 reinfection in individuals with natural and hybrid immunity.
    Suleyman G; Fadel R; Patel K; Shadid AM; Stuart HBC; Kattula M; Janis A; Maki M; Chao S; Alangaden G; Brar I
    J Infect Public Health; 2023 Aug; 16(8):1262-1268. PubMed ID: 37302273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents.
    Patalon T; Saciuk Y; Perez G; Peretz A; Ben-Tov A; Gazit S
    J Pediatr; 2023 Jun; 257():113371. PubMed ID: 36870558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Observation of Immune Response for 23 Months in COVID-19 Convalescent Patients After Infection and Vaccination.
    Xu J; Zheng J; Tan Y; Cai J; Xiang Y; Ling H; Li Z; Bai Q
    Viral Immunol; 2023; 36(6):389-400. PubMed ID: 37276049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective Immunity after Natural Infection with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) - Kentucky, USA, 2020.
    Spicer KB; Glick C; Cavanaugh AM; Thoroughman D
    Int J Infect Dis; 2022 Jan; 114():21-28. PubMed ID: 34649001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection.
    Lewis N; Chambers LC; Chu HT; Fortnam T; De Vito R; Gargano LM; Chan PA; McDonald J; Hogan JW
    JAMA Netw Open; 2022 Jul; 5(7):e2223917. PubMed ID: 35895058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia.
    Jarisch A; Wiercinska E; Huenecke S; Bremm M; Cappel C; Hauler J; Rettinger E; Soerensen J; Hellstern H; Klusmann JH; Ciesek S; Bonig H; Bader P
    Transplant Cell Ther; 2022 Jul; 28(7):366.e1-366.e7. PubMed ID: 35472554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinguishing SARS-CoV-2 infection and vaccine responses up to 18 months post-infection using nucleocapsid protein and receptor-binding domain antibodies.
    Jarlhelt I; Pérez-Alós L; Bayarri-Olmos R; Hansen CB; Petersen MS; Weihe P; Armenteros JJA; Madsen JR; Nielsen JPS; Hilsted LM; Iversen KK; Bundgaard H; Nielsen SD; Garred P
    Microbiol Spectr; 2023 Sep; 11(5):e0179623. PubMed ID: 37738355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers - the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol.
    Wallace S; Hall V; Charlett A; Kirwan PD; Cole M; Gillson N; Atti A; Timeyin J; Foulkes S; Taylor-Kerr A; Andrews N; Shrotri M; Rokadiya S; Oguti B; Vusirikala A; Islam J; Zambon M; Brooks TJG; Ramsay M; Brown CS; Chand M; Hopkins S
    BMJ Open; 2022 Jun; 12(6):e054336. PubMed ID: 35768083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of SARS-CoV-2-Specific Humoral and Cellular Immunity in Coronavirus Disease 2019 Convalescent Health Care Workers in Iraq.
    Hasan Ali I; Sahib Abdulamir A
    Arch Razi Inst; 2021 Nov; 76(5):1255-2127. PubMed ID: 35355770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation.
    Azamor T; Horbach IS; Brito E Cunha D; Melgaço JG; Silva AMVD; Tubarão LN; Azevedo AS; Santos RT; Alves NDS; Machado TL; Silva J; Souza AF; Bayma C; Rocha VP; Frederico ABT; Dias BM; Setatino BP; Denani CB; Campos SPDC; Schwarcz WD; Sucupira MV; Mendes EP; Silva EDD; Barbosa de Lima SM; Ano Bom APD; Missailidis S
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of COVID-19 Vaccination on the Levels of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Naive, Hybrid, and Breakthrough SARS-CoV-2 Recovered Indian Individuals.
    Deepika G; Adarsh S; Sadhana Y; Srihitha M; Veeraiah N; Reddy DN
    J Lab Physicians; 2023 Sep; 15(3):377-382. PubMed ID: 37564232
    [No Abstract]   [Full Text] [Related]  

  • 37. SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination.
    Moore T; Hossain R; Doores KJ; Shankar-Hari M; Fear DJ
    Viral Immunol; 2022 Jul; 35(6):425-436. PubMed ID: 35857310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study.
    Lin DY; Xu Y; Gu Y; Zeng D; Wheeler B; Young H; Moore Z; Sunny SK
    Lancet Infect Dis; 2023 Nov; 23(11):1257-1265. PubMed ID: 37336222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reinfection with SARS-CoV-2 in solid-organ transplant recipients: Incidence density and convalescent immunity prior to reinfection.
    Morris S; Anjan S; Pallikkuth S; Frattaroli P; Courel S; Fernandez A; Natori A; Abbo L; Pahwa S; Guerra G; Natori Y
    Transpl Infect Dis; 2022 Jun; 24(3):e13827. PubMed ID: 35338554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection.
    Hou H; Zhang Y; Tang G; Luo Y; Liu W; Cheng C; Jiang Y; Xiong Z; Wu S; Sun Z; Xu S; Fan X; Wang F
    J Allergy Clin Immunol; 2021 Dec; 148(6):1481-1492.e2. PubMed ID: 34536418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.